Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2023-09-30
2023-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Recovery Kinetics After Different Sprint Training Protocols (STRecovery)
NCT04766411
Speed Endurance Training, Muscle Damage and Performance in Soccer Players
NCT03602248
Recovery of Performance, Muscle Damage and Neuromuscular Fatigue Following Muscle Power Training
NCT03936595
Recovery Kinetics Following a Soccer Training in Middle-aged Males
NCT06260215
Stressors and Recovery Regulation on the Super-compensation Effect
NCT06295016
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Coaches should be careful regarding the frequency of HIIT training during a microcycle, to provide adequate recovery between training sessions to avoid muscle injuries and overtraining. Existing evidence suggests that endurance exercise (continuous or HIIT) may result in exercise-induced muscle damage (EIMD), inflammatory responses, oxidative stress, and performance deterioration, yet, the timeframe of recovery of physiological and biochemical indices following different endurance training protocols has not been adequately studied. However, such information is crucial for coaches to effectively design the most favorable training program for their athletes.
This study aims to examine the acute effect of different continuous and HIIT training protocols on indices of metabolism, EIMD, neuromuscular fatigue and performance in middle- and long-distance runners.
According to a preliminary power analysis (a probability error of 0.05, and a statistical power of 80%), a sample size of 8 subjects per group was considered appropriate in order to detect statistically meaningful changes between groups. Thus, 10 men and female middle- and long-distance runners, will participate in the study.
The study will be performed in a randomized, cross over, repeated measures design. During their first 1st and 2nd visit, all participants will sign an informed consent form after they will be informed about all the benefits and risks of the study and they will fill in and sign a medical history questionnaire. Fasting blood samples will be collected in order to estimate muscle damage concentration markers. Participants will be instructed by a dietitian how to record a 7-days diet recalls to ensure that they do not consume to greater extent nutrients that may affect EIMD and fatigue (e.g. antioxidants, amino acids, etc.) and to ensure that the energy intake during the trials will be the same. Assessment of body mass and body height, body composition, and aerobic capacity (VO2max), will be performed. Using a photocells system, countermovement jump will be performed to assess jump height, and 30 sec Bosco test to assess mean jump height, peak power, mean power, and fatigue index. The peak concentric, eccentric and isometric isokinetic torque of the knee flexors and extensors, in both limbs will be evaluated on an isokinetic dynamometer at 60°/sec. Maximal voluntary isometric contraction (MVIC) of the knee extensors at 65o in both limbs, as well as the fatigue rate during MVIC through the percent drop of peak torque between the first and the last three seconds of a 10-sec MVIC, will also be evaluated. Afterwards, participants will be randomly assigned into, and perform one of the three different conditions of the study design: a) Continuous running (CT) for 40 min at lactic threshold, b) High intensity interval training (HIIT): 10x2min running at vVO2max with active recovery at 40% της VO2max (interval:recovery 1:1) with a load of 10% of body weight (BW), and c) control condition, no training (measurements only). The training protocols will be matched for mean power and total duration (Tschakert and Hofmann 2013). Prior and immediately after each experimental trial, delayed onset of muscle soreness (DOMS) in the knee flexors (KF) and extensors (KE) of both limbs, as well as blood lactate will be assessed. Additionally, DOMS of KF and KE, peak concentric, eccentric and isometric isokinetic torque, CMJ height, as well as mean jump height, peak power, mean power, and fatigue index during a 30 sec Bosco test, will be assessed 24h, 48h and 72h after the end of the trial. MVIC of the knee extensors of both limbs, as well as the fatigue rate during MVIC will also be assessed at 1h, 2h and 3h, as well as 24h, 48h, and 72h after the end of the trial. Creatine kinase will be assessed at 24h, 48h, and 72h after the end of the trial. The exact above procedures will be repeated by the participants during the remaining two experimental trials. A 2-weeks wash-out period will be implemented between trials.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Intensity Interval Training
The participants will perform an acute bout of high intensity interval training
High Intensity Interval Training
10 x 2 min running at vVO2max, interspersed by 2 min recovery at 40% VO2max
Coninuous Running
The participants will perform an acute bout of continuous running
Coninuous Running
40 min continuous running at lactate threshold
Control Trial
The participants will not perform any endurance exercise protocol
Control Trial
The participants will perform only the baseline and post acute-training evaluations, without performing exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Intensity Interval Training
10 x 2 min running at vVO2max, interspersed by 2 min recovery at 40% VO2max
Coninuous Running
40 min continuous running at lactate threshold
Control Trial
The participants will perform only the baseline and post acute-training evaluations, without performing exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Absence of musculoskeletal injuries (≥ 6 months)
* No use of drugs or ergogenic supplements (≥ 1 month)
* Absense from eccentric exercise (≥ 3 days)
* No alcohol or ergogenic drinks consumption before each training protocol
Exclusion Criteria
* Use of drugs or ergogenic supplements (\< 1 month)
* Participation in eccentric exercise (\< 3 days)
* Alcohol or ergogenic drinks consumption before the training protocol
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Thessaly
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chariklia K. Deli
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chariklia K Deli, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Thessaly
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Physical Education and Sport Science, Uninersity of Thessaly
Trikala, Thessaly, Greece
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barnes KR, Kilding AE. Strategies to improve running economy. Sports Med. 2015 Jan;45(1):37-56. doi: 10.1007/s40279-014-0246-y.
Brandao LHA, Chagas TPN, Vasconcelos ABS, de Oliveira VC, Fortes LS, de Almeida MB, Mendes Netto RS, Del-Vecchio FB, Neto EP, Chaves LMS, Jimenez-Pavon D, Da Silva-Grigoletto ME. Physiological and Performance Impacts After Field Supramaximal High-Intensity Interval Training With Different Work-Recovery Duration. Front Physiol. 2020 Oct 8;11:1075. doi: 10.3389/fphys.2020.01075. eCollection 2020.
Cipryan L. IL-6, Antioxidant Capacity and Muscle Damage Markers Following High-Intensity Interval Training Protocols. J Hum Kinet. 2017 Mar 15;56:139-148. doi: 10.1515/hukin-2017-0031. eCollection 2017 Feb.
Esfarjani F, Laursen PB. Manipulating high-intensity interval training: effects on VO2max, the lactate threshold and 3000 m running performance in moderately trained males. J Sci Med Sport. 2007 Feb;10(1):27-35. doi: 10.1016/j.jsams.2006.05.014. Epub 2006 Jul 28.
Hottenrott K, Ludyga S, Schulze S. Effects of high intensity training and continuous endurance training on aerobic capacity and body composition in recreationally active runners. J Sports Sci Med. 2012 Sep 1;11(3):483-8. eCollection 2012.
Martinez-Ferran M, Cuadrado-Penafiel V, Sanchez-Andreo JM, Villar-Lucas M, Castellanos-Montealegre M, Rubio-Martin A, Romero-Morales C, Casla-Barrio S, Pareja-Galeano H. Effects of Acute Vitamin C plus Vitamin E Supplementation on Exercise-Induced Muscle Damage in Runners: A Double-Blind Randomized Controlled Trial. Nutrients. 2022 Nov 3;14(21):4635. doi: 10.3390/nu14214635.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Endurance Training - Recovery
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.